×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CDXS – codexis, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CDXS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/4
12:06 am
cdxs
Codexis' ECO Synthesis® Manufacturing Platform: Transforming RNA Therapeutics [CBS News]
Medium
Report
Codexis' ECO Synthesis® Manufacturing Platform: Transforming RNA Therapeutics [CBS News]
11/17
08:21 am
cdxs
Sonoma Biotherapeutics Announces Transition of Jeff Bluestone, PhD, to Advisor; Appoints Stephen Dilly, MBBS, PhD, as President and Chief Executive Officer [Yahoo! Finance]
Low
Report
Sonoma Biotherapeutics Announces Transition of Jeff Bluestone, PhD, to Advisor; Appoints Stephen Dilly, MBBS, PhD, as President and Chief Executive Officer [Yahoo! Finance]
11/10
09:21 am
cdxs
Codexis Announces Signing of Lease for GMP Manufacturing Facility [Yahoo! Finance]
Low
Report
Codexis Announces Signing of Lease for GMP Manufacturing Facility [Yahoo! Finance]
11/10
09:00 am
cdxs
Codexis Announces Signing of Lease for GMP Manufacturing Facility
Low
Report
Codexis Announces Signing of Lease for GMP Manufacturing Facility
11/8
01:17 pm
cdxs
Codexis (NASDAQ:CDXS) was downgraded by analysts at Wall Street Zen
Low
Report
Codexis (NASDAQ:CDXS) was downgraded by analysts at Wall Street Zen
11/6
04:21 pm
cdxs
Codexis Reports Third Quarter 2025 Financial Results
High
Report
Codexis Reports Third Quarter 2025 Financial Results
10/29
10:02 am
cdxs
Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing
Medium
Report
Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing
10/29
09:58 am
cdxs
Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing
Medium
Report
Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/1
05:42 pm
cdxs
Form 4 CODEXIS, INC. For: Nov 26 Filed by: Opaleye Management Inc.
Low
Report
Form 4 CODEXIS, INC. For: Nov 26 Filed by: Opaleye Management Inc.
11/25
04:19 pm
cdxs
Form 4 CODEXIS, INC. For: Nov 21 Filed by: WOLF DENNIS P
Medium
Report
Form 4 CODEXIS, INC. For: Nov 21 Filed by: WOLF DENNIS P
11/21
04:52 pm
cdxs
Form 144 CODEXIS, INC. Filed by: WOLF DENNIS P
Medium
Report
Form 144 CODEXIS, INC. Filed by: WOLF DENNIS P
11/17
05:11 pm
cdxs
Form 4 CODEXIS, INC. For: Nov 13 Filed by: MOORE ALISON
Medium
Report
Form 4 CODEXIS, INC. For: Nov 13 Filed by: MOORE ALISON
11/17
05:11 pm
cdxs
Form 3 CODEXIS, INC. For: Nov 07 Filed by: Lutz Stefan
Medium
Report
Form 3 CODEXIS, INC. For: Nov 07 Filed by: Lutz Stefan
11/14
05:16 pm
cdxs
Form SCHEDULE 13G/A CODEXIS, INC. Filed by: Casdin Capital, LLC
Medium
Report
Form SCHEDULE 13G/A CODEXIS, INC. Filed by: Casdin Capital, LLC
11/14
04:18 pm
cdxs
Form 4 CODEXIS, INC. For: Nov 12 Filed by: Opaleye Management Inc.
Medium
Report
Form 4 CODEXIS, INC. For: Nov 12 Filed by: Opaleye Management Inc.
11/12
04:31 pm
cdxs
Form 4 CODEXIS, INC. For: Nov 11 Filed by: DILLY STEPHEN GEORGE
Medium
Report
Form 4 CODEXIS, INC. For: Nov 11 Filed by: DILLY STEPHEN GEORGE
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/23
Codexis, Inc. (NASDAQ: CDXS) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.
12.1%
3/23 Codexis Signs Strategic Collaboration and License Agreement with Takeda to Advance Novel Gene Therapies for Rare Genetic Disorders 11.0%
11/5 Q3/2019 9/30/2019 EPS 0.040 ZacksConsensus -0.090 ActVsEst 0.130 - Beat 9.4%
8/26 Form 4 CODEXIS, INC. For: Aug 22 Filed by: Yang Patrick Y 7.7%
4/3 Form 4 CODEXIS, INC. For: Apr 01 Filed by: BARUCH THOMAS R 6.6%
3/27 Form 4 CODEXIS, INC. For: Mar 25 Filed by: WOLF DENNIS P 5.7%
3/4 Codexis, Inc. (NASDAQ: CDXS) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. 5.6%
3/5 Codexis, Inc. (NASDAQ: CDXS) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 4.8%
4/8 Codexis, Inc. (NASDAQ: CDXS) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 4.3%
9/4 Form 4 CODEXIS, INC. For: Sep 03 Filed by: Yang Patrick Y 3.6%
3/23 Codexis Signs Strategic Collaboration and License Agreement with Takeda to Advance Novel Gene Therapies for Rare Genetic Disorders 11.0%
11/5 Q3/2019 9/30/2019 EPS 0.040 ZacksConsensus -0.090 ActVsEst 0.130 - Beat 9.4%
8/26 Form 4 CODEXIS, INC. For: Aug 22 Filed by: Yang Patrick Y 7.7%
4/3 Form 4 CODEXIS, INC. For: Apr 01 Filed by: BARUCH THOMAS R 6.6%
3/27 Form 4 CODEXIS, INC. For: Mar 25 Filed by: WOLF DENNIS P 5.7%
3/4 Codexis, Inc. (NASDAQ: CDXS) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. 5.6%
3/5 Codexis, Inc. (NASDAQ: CDXS) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 4.8%
4/8 Codexis, Inc. (NASDAQ: CDXS) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 4.3%
9/4 Form 4 CODEXIS, INC. For: Sep 03 Filed by: Yang Patrick Y 3.6%
TOP News Decliners
8/6
Form 10-Q CODEXIS, INC. For: Jun 30
-18.3%
2/28 Codexis, Inc. (NASDAQ: CDXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.50 price target on the stock. -12.2%
5/7 Codexis, Inc. (CDXS) CEO John Nicols on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] -8.2%
4/15 Near a 2-Year Low, Is Codexis Stock a Buy? [The Motley Fool] -7.1%
5/10 Codexis, Inc. (NASDAQ: CDXS) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -6.5%
12/24 Codexis, Inc. (NASDAQ: CDXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.50 price target on the stock. -5.2%
2/25 Codexis to Present at Two Investment Conferences in March -4.1%
5/22 Codexis (CDXS) Presents At UBS Global Healthcare Conference - Slideshow [Seeking Alpha] -3.9%
4/23 Form 4 CODEXIS, INC. For: Apr 21 Filed by: KELLEY BERNARD J -3.6%
7/23 Form 8-K CODEXIS, INC. For: Jul 19 -3.5%
2/28 Codexis, Inc. (NASDAQ: CDXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.50 price target on the stock. -12.2%
5/7 Codexis, Inc. (CDXS) CEO John Nicols on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] -8.2%
4/15 Near a 2-Year Low, Is Codexis Stock a Buy? [The Motley Fool] -7.1%
5/10 Codexis, Inc. (NASDAQ: CDXS) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -6.5%
12/24 Codexis, Inc. (NASDAQ: CDXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.50 price target on the stock. -5.2%
2/25 Codexis to Present at Two Investment Conferences in March -4.1%
5/22 Codexis (CDXS) Presents At UBS Global Healthcare Conference - Slideshow [Seeking Alpha] -3.9%
4/23 Form 4 CODEXIS, INC. For: Apr 21 Filed by: KELLEY BERNARD J -3.6%
7/23 Form 8-K CODEXIS, INC. For: Jul 19 -3.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: